Effects of statins on the immunoglobulin G glycome

Biochimica et Biophysica Acta - General Subjects

Volumn 1861, Issue 5, 2017, Pages 1152-1158

  Keser, Toma ^a   Vučković, Frano ^b   Barrios, Clara ^c,d   Zierer, Jonas ^c,e   Wahl, Annika ^e,f   Akinkuolie, Akintunde O ^g   Štambuk, Jerko ^b   Nakić, Natali ^h   Pavić, Tamara ^a   Periša, Josipa ^a   Mora, Samia ^g   Gieger, Christian ^e,f   Menni, Cristina ^c   Spector, Tim D ^c   Gornik, Olga ^a   Lauc, Gordan ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HOSPITAL DEL MAR   (Spain)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h SISSA   (Italy)

Author keywords

Immunoglobulin G; N glycosylation; Rosuvastatin; Statin; Total plasma N glycome

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; GLYCAN; GLYCOPEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; MEVINOLIN; N ACETYLGLUCOSAMINE; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; GLYCOSYLATED IGG; POLYSACCHARIDE; SULFONAMIDE;

ADULT; AGED; ARTICLE; CARBOHYDRATE ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FUCOSYLATION; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVERSED PHASE LIQUID CHROMATOGRAPHY; RISK ASSESSMENT; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; METABOLISM; PROCEDURES; RISK FACTOR;

ACETYLGLUCOSAMINE; AGED; DOUBLE-BLIND METHOD; FEMALE; GLYCOMICS; GLYCOSYLATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; POLYSACCHARIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SULFONAMIDES;

EID: 85014608495     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2017.02.029     Document Type: Article

References (44)

1. [1] Kobata, A., A retrospective and prospective view of glycopathology. Glycoconj. J. 15 (1998), 323–331 ( http://www.ncbi.nlm.nih.gov/pubmed/9613818, accessed February 8, 2016).
2. [2] Spiro, R.G., Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12 (2002), 43R–56R ( http://www.ncbi.nlm.nih.gov/pubmed/12042244, accessed February 8, 2016).
3. [3] Miura, Y., Hashii, N., Tsumoto, H., Takakura, D., Ohta, Y., Abe, Y., Arai, Y., Kawasaki, N., Hirose, N., Endo, T., Change in N-glycosylation of plasma proteins in Japanese semisupercentenarians. PLoS One, 10, 2015, e0142645, 10.1371/journal.pone.0142645.
4. [4] Clerc, F., Reiding, K.R., Jansen, B.C., Kammeijer, G.S.M., Bondt, A., Wuhrer, M., Human plasma protein N-glycosylation. Glycoconj. J., 2015, 10.1007/s10719–015–9626-2.
5. [5] Knežević, A., Gornik, O., Polašek, O., Pučić, M., Redžić, I., Novokmet, M., Rudd, P.M., Wright, A.F., Campbell, H., Rudan, I., Lauc, G., Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 20 (2010), 959–969, 10.1093/glycob/cwq051.
6. [6] Knežević, A., Polašek, O., Gornik, O., Rudan, I., Campbell, H., Hayward, C., Wright, A., Kolčić, I., O'Donoghue, N., Bones, J., Rudd, P.M., Lauc, G., Variability, heritability and environmental determinants of human plasma N-glycome. J. Proteome Res. 8 (2009), 694–701, 10.1021/pr800737u.
7. [7] Pučić, M., Knežević, A., Vidić, J., Adamczyk, B., Novokmet, M., Polašek, O., Gornik, O., Šupraha-Goreta, S., Wormald, M.R., Redžić, I., Campbell, H., Wright, A., Hastie, N.D., Wilson, J.F., Rudan, I., Wuhrer, M., Rudd, P.M., Josić, D., Lauc, G., High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell. Proteomics, 10, 2011 (M111.010090) 10.1074/mcp.M111.010090.
8. [8] Huffman, J.E., Knezevic, A., Vitart, V., Kattla, J., Adamczyk, B., Novokmet, M., Igl, W., Pucic, M., Zgaga, L., Johannson, Å., Redzic, I., Gornik, O., Zemunik, T., Polasek, O., Kolcic, I., Pehlic, M., Koeleman, C.A.M., Campbell, S., Wild, S.H., Hastie, N.D., Campbell, H., Gyllensten, U., Wuhrer, M., Wilson, J.F., Hayward, C., Rudan, I., Rudd, P.M., Wright, A.F., Lauc, G., Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. Hum. Mol. Genet. 20 (2011), 5000–5011, 10.1093/hmg/ddr414.
9. [9] Dall'Olio, F., Vanhooren, V., Chen, C.C., Slagboom, P.E., Wuhrer, M., Franceschi, C., N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res. Rev. 12 (2013), 685–698, 10.1016/j.arr.2012.02.002.
10. [10] Saldova, R., Huffman, J.E., Adamczyk, B., Mužinić, A., Kattla, J.J., Pučić, M., Novokmet, M., Abrahams, J.L., Hayward, C., Rudan, I., Wild, S.H., Wright, A.F., Polašek, O., Lauc, G., Campbell, H., Wilson, J.F., Rudd, P.M., Association of medication with the human plasma N-glycome. J. Proteome Res. 11 (2012), 1821–1831, 10.1021/pr2010605.
11. [11] Akinkuolie, A.O., Buring, J.E., Ridker, P.M., Mora, S., A novel protein glycan biomarker and future cardiovascular disease events. J. Am. Heart Assoc., 3, 2014, e001221, 10.1161/JAHA.114.001221.
12. [12] Hadžibegović, I., Vrselja, Z., Lauc, G., Curić, G., Expression of leukocyte adhesion-related glycosyltransferase genes in acute coronary syndrome patients. Inflamm. Res. 63 (2014), 629–636, 10.1007/s00011-014-0735-3.
13. [13] Krištić, J., Vučković, F., Menni, C., Klarić, L., Keser, T., Beceheli, I., Pučić-Baković, M., Novokmet, M., Mangino, M., Thaqi, K., Rudan, P., Novokmet, N., Šarac, J., Missoni, S., Kolčić, I., Polašek, O., Rudan, I., Campbell, H., Hayward, C., Aulchenko, Y., Valdes, A., Wilson, J.F., Gornik, O., Primorac, D., Zoldoš, V., Spector, T., Lauc, G., Glycans are a novel biomarker of chronological and biological ages. J. Gerontol. A Biol. Sci. Med. Sci., 69, 2014, 10.1093/gerona/glt190.
14. [14] Barrios, C., Zierer, J., Gudelj, I., Štambuk, J., Ugrina, I., Rodríguez, E., Soler, M.J., Pavić, T., Šimurina, M., Keser, T., Pučić-Baković, M., Mangino, M., Pascual, J., Spector, T.D., Lauc, G., Menni, C., Glycosylation profile of IgG in moderate kidney dysfunction. J. Am. Soc. Nephrol. 27 (2016), 933–941, 10.1681/ASN.2015010109.
15. [15] Nikolac Perkovic, M., Pucic Bakovic, M., Kristic, J., Novokmet, M., Huffman, J.E., Vitart, V., Hayward, C., Rudan, I., Wilson, J.F., Campbell, H., Polasek, O., Lauc, G., Pivac, N., The association between galactosylation of immunoglobulin G and body mass index. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 48 (2014), 20–25, 10.1016/j.pnpbp.2013.08.014.
16. [16] Maron, D.J., Fazio, S., Linton, M.F., Current perspectives on statins. Circulation 101 (2000), 207–213 ( http://www.ncbi.nlm.nih.gov/pubmed/10637210, accessed June 21, 2016).
17. [17] Mora, S., Glynn, R.J., Hsia, J., MacFadyen, J.G., Genest, J., Ridker, P.M., Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia. Circulation 121 (2010), 1069–1077, 10.1161/CIRCULATIONAHA.109.906479.
18. [18] Lefer, D.J., Statins as potent antiinflammatory drugs. Circulation 106 (2002), 2041–2042, 10.1161/01.CIR.0000033635.42612.88.
19. [19] Ridker, P.M., Danielson, E., Fonseca, F.A.H., Genest, J., Gotto, A.M., Kastelein, J.J.P., Koenig, W., Libby, P., Lorenzatti, A.J., MacFadyen, J.G., Nordestgaard, B.G., Shepherd, J., Willerson, J.T., Glynn, R.J., JUPITER Study Group, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359 (2008), 2195–2207, 10.1056/NEJMoa0807646.
20. [20] Gornik, O., Lauc, G., Glycosylation of serum proteins in inflammatory diseases. Dis. Markers 25 (2008), 267–278 ( http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3827815&tool=pmcentrez&rendertype=abstract).
21. [21] Anthony, R.M., Kobayashi, T., Wermeling, F., Ravetch, J.V., Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 475 (2011), 110–113, 10.1038/nature10134.
22. [22] Boyd, P.N., Lines, A.C., Patel, A.K., The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. Mol. Immunol. 32 (1995), 1311–1318 ( http://www.ncbi.nlm.nih.gov/pubmed/8643100, accessed February 9, 2016).
23. [23] Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J., Young, S.P., Goodall, M., Jefferis, R., Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J. Biol. Chem. 276 (2001), 45539–45547, 10.1074/jbc.M107478200.
24. [24] Moayyeri, A., Hammond, C.J., Valdes, A.M., Spector, T.D., Cohort Profile: TwinsUK and healthy ageing twin study. Int. J. Epidemiol. 42 (2013), 76–85, 10.1093/ije/dyr207.
25. [25] Wichmann, H.-E., Gieger, C., Illig, T., MONICA/KORA Study Group, KORA-gen—resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswes (Bundesverband Der Ärzte Des Öffentlichen Gesundheitsdienstes) 67:Suppl. 1 (2005), S26–S30, 10.1055/s-2005-858226.
26. [26] Royle, L., Radcliffe, C.M., Dwek, R.A., Rudd, P.M., Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Glycobiol. Protoc, 2006, Humana Press, New Jersey, 125–144, 10.1385/1-59745-167-3:125.
27. [27] Campbell, M.P., Royle, L., Radcliffe, C.M., Dwek, R.A., Rudd, P.M., GlycoBase and autoGU: tools for HPLC-based glycan analysis. Bioinformatics 24 (2008), 1214–1216, 10.1093/bioinformatics/btn090.
28. [28] Balbín, M., Grubb, A., de Lange, G.G., Grubb, R., DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics 39 (1994), 187–193 ( http://www.ncbi.nlm.nih.gov/pubmed/8276465, accessed July 1, 2016).
29. [29] Huffman, J.E., Pučić-Baković, M., Klarić, L., Hennig, R., Selman, M.H.J., Vučković, F., Novokmet, M., Krištić, J., Borowiak, M., Muth, T., Polašek, O., Razdorov, G., Gornik, O., Plomp, R., Theodoratou, E., Wright, A.F., Rudan, I., Hayward, C., Campbell, H., Deelder, A.M., Reichl, U., Aulchenko, Y.S., Rapp, E., Wuhrer, M., Lauc, G., Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol. Cell. Proteomics 13 (2014), 1598–1610, 10.1074/mcp.M113.037465.
30. [30] Malhotra, R., Wormald, M.R., Rudd, P.M., Fischer, P.B., Dwek, R.A., Sim, R.B., Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1 (1995), 237–243 ( http://www.ncbi.nlm.nih.gov/pubmed/7585040, accessed February 9, 2016).
31. [31] Karsten, C.M., Pandey, M.K., Figge, J., Kilchenstein, R., Taylor, P.R., Rosas, M., McDonald, J.U., Orr, S.J., Berger, M., Petzold, D., Blanchard, V., Winkler, A., Hess, C., Reid, D.M., Majoul, I.V., Strait, R.T., Harris, N.L., Köhl, G., Wex, E., Ludwig, R., Zillikens, D., Nimmerjahn, F., Finkelman, F.D., Brown, G.D., Ehlers, M., Köhl, J., Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nat. Med. 18 (2012), 1401–1406, 10.1038/nm.2862.
32. [32] Mihai, S., Nimmerjahn, F., The role of Fc receptors and complement in autoimmunity. Autoimmun. Rev. 12 (2013), 657–660, 10.1016/j.autrev.2012.10.008.
33. [33] Krištić, J., Vučković, F., Menni, C., Klarić, L., Keser, T., Bečeheli, I., Pučić-Baković, M., Novokmet, M., Mangino, M., Thaqi, K., Rudan, P., Novokmet, N., Šarac, J., Missoni, S., Kolčić, I., Polašek, O., Rudan, I., Campbell, H., Hayward, C., Aulchenko, Y., Valdes, A., Wilson, J.F., Gornik, O., Primorac, D., Zoldoš, V., Spector, T., Lauc, G., Glycans are a novel biomarker of chronological and biological ages. J. Gerontol. A Biol. Sci. Med. Sci. 69 (2014), 779–789, 10.1093/gerona/glt190.
34. [34] Vučković, F., Krištić, J., Gudelj, I., Teruel, M., Keser, T., Pezer, M., Pučić-Baković, M., Štambuk, J., Trbojević-Akmačić, I., Barrios, C., Pavić, T., Menni, C., Wang, Y., Zhou, Y., Cui, L., Song, H., Zeng, Q., Guo, X., Pons-Estel, B.A., McKeigue, P., Leslie Patrick, A., Gornik, O., Spector, T.D., Harjaček, M., Alarcon-Riquelme, M., Molokhia, M., Wang, W., Lauc, G., Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol. (Hoboken, N.J.) 67 (2015), 2978–2989, 10.1002/art.39273.
35. [35] Trbojević Akmačić, I., Ventham, N.T., Theodoratou, E., Vučković, F., Kennedy, N.A., Krištić, J., Nimmo, E.R., Kalla, R., Drummond, H., Štambuk, J., Dunlop, M.G., Novokmet, M., Aulchenko, Y., Gornik, O., Campbell, H., Pučić Baković, M., Satsangi, J., Lauc, G., Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm. Bowel Dis. 21 (2015), 1237–1247, 10.1097/MIB.0000000000000372.
36. [36] Theodoratou, E., Thaçi, K., Agakov, F., Timofeeva, M.N., Štambuk, J., Pučić-Baković, M., Vučković, F., Orchard, P., Agakova, A., Din, F.V.N., Brown, E., Rudd, P.M., Farrington, S.M., Dunlop, M.G., Campbell, H., Lauc, G., Glycosylation of plasma IgG in colorectal cancer prognosis. Sci. Rep., 6, 2016, 28098, 10.1038/srep28098.
37. [37] Quast, I., Keller, C.W., Maurer, M.A., Giddens, J.P., Tackenberg, B., Wang, L.-X., Münz, C., Nimmerjahn, F., Dalakas, M.C., Lünemann, J.D., Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J. Clin. Invest. 125 (2015), 4160–4170, 10.1172/JCI82695.
38. [38] Campbell, I.K., Miescher, S., Branch, D.R., Mott, P.J., Lazarus, A.H., Han, D., Maraskovsky, E., Zuercher, A.W., Neschadim, A., Leontyev, D., McKenzie, B.S., Käsermann, F., Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J. Immunol. 192 (2014), 5031–5038, 10.4049/jimmunol.1301611.
39. [39] Issekutz, A.C., Rowter, D., Miescher, S., Käsermann, F., Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells. Clin. Immunol. 160 (2015), 123–132, 10.1016/j.clim.2015.05.003.
40. [40] Mariño, K., Saldova, R., Adamczyk, B., Rudd, P.M., Changes in serum N-glycosylation profiles: functional significance and potential for diagnostics. Pilar Rauter, A., (eds.) Carbohydr. Chem, 37th ed., 2012, The Royal Society of Chemistry, Cambridge, UK, 57–93, 10.1039/9781849732765-00057.
41. [41] Moremen, K.W., Tiemeyer, M., Nairn, A.V., Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13 (2012), 448–462, 10.1038/nrm3383.
42. [42] Dall'Olio, F., Malagolini, N., Trinchera, M., Chiricolo, M., Mechanisms of cancer-associated glycosylation changes. Front. Biosci. (Landmark Ed.) 17 (2012), 670–699 ( http://www.ncbi.nlm.nih.gov/pubmed/22201768, accessed January 20, 2017).
43. [43] Yarema, K.J., Bertozzi, C.R., Characterizing glycosylation pathways. Genome Biol., 2, 2001, REVIEWS0004 ( http://www.ncbi.nlm.nih.gov/pubmed/11387039, accessed January 20, 2017).
44. [44] Menni, C., Keser, T., Mangino, M., Bell, J.T., Erte, I., Akmačić, I., Vučković, F., Pučić Baković, M., Gornik, O., McCarthy, M.I., Zoldoš, V., Spector, T.D., Lauc, G., Valdes, A.M., Glycosylation of immunoglobulin G: Role of genetic and epigenetic influences. PLoS One, 8, 2013.